TORONTO, ONTARIO--(Marketwired - April 22, 2013) - Titan Medical Inc. (the "Company") (TSX VENTURE:TMD)(OTCQX:TITXF) today announces that it has successfully completed the design and fabrication of beta versions of its highly dexterous instruments for use with the Company's Single Incision robotic surgical system. The instruments are designed to meet the requirements for single incision surgery and will offer unprecedented dexterity under robotic control. The instruments were developed in conjunction with a leading medical technology development firm.

"The single incision instruments are highly dexterous, offering seven degrees of freedom per instrument to the surgeon. This unprecedented capability will allow surgeons precise control and capability for single incision surgery at a less expensive price point," commented Dr. Reiza Rayman, President, Titan Medical Inc.

The Company is moving forward with the development of its Single Incision robotic surgical system and remains on track to commercialization.

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company (TSX VENTURE:TMD)(OTCQX:TITXF) focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's robotic surgical system, currently under development, comprises a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The robotic surgical system is being designed to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are currently under-serviced, and to allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. For more information, visit the Company's website at [ www.titanmedicalinc.com ].

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form dated April 10, 2013 (which may be viewed at [ www.sedar.com ]). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

Contributing Sources

---

Market Wire